July 22, 2014
Background: Since 1998, randomised trials in India funded by the US National Cancer Institute (NCI) and the Bill and Melinda Gates Foundation have compared cervical cancer death rates among 224,929 women offered cervical screening to those among 138,624 women offered no screening whatsoever. To d...
Eric J Suba
July 22, 2014
Dr Eric Suba has been distorting facts and persistently disseminating biased and misleading views and statements regarding our studies over the past several years. His article in the Indian Journal of Medical Ethics fails to mention the facts that seem unfavourable to his arguments, and the ethic...
Rengaswamy Sankaranarayanan, Bhagwan M Nene, Surendra Shastri, Pullikotil Ekkuru Esmy, Rajamanickam Rajkumar, Richard Muwonge, Rajaraman Swaminathan, Sylla G Malvi, Shubada Kane, Sangeeta Desai, Rohini Kelkar, Sanjay Hingmire, Kasturi Jayant
July 22, 2014
During the 1970s and 1980s, reports from several countries documented substantial reductions in incidence rates of cervical cancer and death rates following the introduction of cervical screening and confirmed the role of cervical screening as an archetypal preventive health intervention; moreove...
Eric J Suba
October 01, 2013
Pramesh and colleagues have not responded to my central thesis: it was unethical to have a "no screening" control arm in the VIA trials when proven screening methods existed
Sandhya Srinivasan
October 01, 2013
The Xpert® MTB/RIF (hereafter Xpert) is a recent technology that has "demonstrated sensitive detection of tuberculosis (TB) and rifampicin resistance directly from untreated sputum in less than two hours" . Many are in favour of the widespread implementation of this technology in India. In a r...
Richard A Cash
October 01, 2013
We read with interest the recent editorial in the IJME on the ethics of standard care in screening trials for cervical cancer in India. The author takes exception to the fact that three cervical cancer screening studies in India used no screening as the control arm, in spite of evidence that ...
C S Pramesh, Surendra Shastri, Indraneel Mittra, Rajendra A Badwe
July 01, 2005
There is rejuvenated interest within modern medicine in end-of-life issues including the care of terminally ill and dying patients. Technological advances in the last few decades have made us believe that death is an unnatural event and that life can be prolonged at will. This has resulted in the...
S K Jindal
July 01, 2005
As medical practice becomes increasingly technology oriented, health-care expenditure has also increased significantly . At the same time, there have long been calls that medical technologies like other social goods should be distributed by rational criteria, especially when resources are scarce.
Suhita Chopra Chatterjee, Sweta Mohanty
July 01, 2005
As an invasive cardiologist in the US I deal with end-of-life issues almost daily. It is my experience that many elderly patients survive cardiac arrests with a very poor quality of life or in a vegetative state. I have seen too many such patients living a miserable life for months in a hospital ...
Anil Kumar Rastogi
July 01, 2005
As one reaches the final station of life, there is a plethora of issues that we confront, involving the patient, the family and the caregiver. While much work has been done on the joyous beginning of life, death is a neglected subject.
S N Simha
